|
Sen. Laura Fine
Filed: 3/12/2025
| | 10400SB2259sam001 | | LRB104 09338 AAS 23205 a |
|
|
1 | | AMENDMENT TO SENATE BILL 2259
|
2 | | AMENDMENT NO. ______. Amend Senate Bill 2259 by replacing |
3 | | everything after the enacting clause with the following: |
4 | | "Section 5. The Medical Practice Act of 1987 is amended by |
5 | | adding Section 67 as follows: |
6 | | (225 ILCS 60/67 new) |
7 | | Sec. 67. Use of generative artificial intelligence. |
8 | | (a) As used in this Section: |
9 | | "Generative artificial intelligence" means an automated |
10 | | computing system that, when prompted with human prompts, |
11 | | descriptions, or queries, can produce outputs that simulate |
12 | | human-produced content, including, but not limited to, the |
13 | | following: |
14 | | (1) textual outputs, such as short answers, essays, |
15 | | poetry, or longer compositions or answers; |
16 | | (2) image outputs, such as fine art, photographs, |
|
| | 10400SB2259sam001 | - 2 - | LRB104 09338 AAS 23205 a |
|
|
1 | | conceptual art, diagrams, and other images; |
2 | | (3) multimedia outputs, such as audio or video in the |
3 | | form of compositions, songs, or short-form or long-form |
4 | | audio or video; and |
5 | | (4) other content that would be otherwise produced by |
6 | | human means. |
7 | | "Patient clinical information" means information relating |
8 | | to the health status of a patient. "Patient clinical |
9 | | information" does not include administrative matters, |
10 | | including, but not limited to, appointment scheduling, |
11 | | billing, or other clerical or business matters. |
12 | | (b) A physician licensed under this Act who uses |
13 | | generative artificial intelligence to generate written or |
14 | | verbal patient communications pertaining to patient clinical |
15 | | information shall ensure that the communications include both |
16 | | of the following: |
17 | | (1) A disclaimer that indicates to the patient that |
18 | | the communication was generated by generative artificial |
19 | | intelligence and that is provided in the following manner: |
20 | | (A) for written communications involving physical |
21 | | and digital media, including letters, emails, and |
22 | | other occasional messages, the disclaimer shall appear |
23 | | prominently at the beginning of each communication; |
24 | | (B) for written communications involving |
25 | | continuous online interactions, including chat-based |
26 | | telehealth, the disclaimer shall be prominently |
|
| | 10400SB2259sam001 | - 3 - | LRB104 09338 AAS 23205 a |
|
|
1 | | displayed throughout the interaction; |
2 | | (C) for audio communications, the disclaimer shall |
3 | | be provided verbally at the start and the end of the |
4 | | interaction; or |
5 | | (D) for video communications, the disclaimer shall |
6 | | be prominently displayed throughout the interaction. |
7 | | (2) Clear instructions describing how a patient may |
8 | | contact the physician or other appropriate person. |
9 | | (c) If a communication is generated by generative |
10 | | artificial intelligence and read and reviewed by a human |
11 | | licensed under this Act or by someone otherwise appropriately |
12 | | delegated to under Sections 54.2 and 54.5, the requirements of |
13 | | subsection (b) do not apply. |
14 | | (d) A violation of this Section by a physician shall |
15 | | constitute a violation of this Act and shall be grounds for |
16 | | disciplinary action provided for in this Act. ". |